Float Short %

12.45

Margin Of Safety %

Put/Call OI Ratio

0.18

EPS Next Q Diff

0.02

EPS Last/This Y

0.55

EPS This/Next Y

0.39

Price

0.36

Target Price

6.75

Analyst Recom

Performance Q

-85.91

Relative Volume

0.12

Beta

-0.23

Ticker: LPTX

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-03-21	LPTX	0.4001	0.24	0.00	5658
2025-03-24	LPTX	0.3925	0.09	0.00	2814
2025-03-25	LPTX	0.3999	0.07	0.00	2869
2025-03-26	LPTX	0.4516	0.07	0.49	2862
2025-03-27	LPTX	0.3647	0.19	0.00	4406
2025-03-28	LPTX	0.315	0.19	0.00	4380
2025-03-31	LPTX	0.3108	0.18	0.08	4536
2025-04-01	LPTX	0.2975	0.18	0.08	4536
2025-04-02	LPTX	0.326	0.18	0.06	4540
2025-04-03	LPTX	0.3051	0.18	0.00	4556
2025-04-04	LPTX	0.2653	0.18	0.00	4563
2025-04-07	LPTX	0.2972	0.18	0.00	4593
2025-04-08	LPTX	0.2564	0.18	0.00	4603
2025-04-09	LPTX	0.3193	0.18	0.00	4600
2025-04-10	LPTX	0.308	0.18	0.00	4550
2025-04-11	LPTX	0.3163	0.18	0.00	4568
2025-04-14	LPTX	0.3485	0.18	10.20	4634
2025-04-15	LPTX	0.3604	0.18	0.00	4663
2025-04-16	LPTX	0.359	0.18	0.00	4664
2025-04-17	LPTX	0.3607	0.18	0.00	4779
2025-04-18	LPTX	0.3634	0.18	0.00	4779
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-03-21	LPTX	0.39	-92.5	-	-1.83
2025-03-24	LPTX	0.39	-92.5	-	-1.83
2025-03-25	LPTX	0.39	-92.5	-	-1.83
2025-03-26	LPTX	0.45	-92.5	-	-1.83
2025-03-27	LPTX	0.36	-92.5	-	-1.83
2025-03-28	LPTX	0.32	33.3	-	-1.14
2025-03-31	LPTX	0.31	25.5	-	-1.26
2025-04-01	LPTX	0.29	25.5	-	-1.26
2025-04-02	LPTX	0.34	25.5	-	-1.26
2025-04-03	LPTX	0.31	25.5	-	-1.26
2025-04-04	LPTX	0.27	25.5	-	-1.26
2025-04-07	LPTX	0.29	25.5	-	-1.26
2025-04-08	LPTX	0.27	25.5	-	-1.26
2025-04-09	LPTX	0.30	25.5	-	-1.26
2025-04-10	LPTX	0.31	25.5	-	-1.26
2025-04-11	LPTX	0.32	25.5	-	-1.26
2025-04-14	LPTX	0.34	25.5	-	-1.26
2025-04-15	LPTX	0.37	25.5	-	-1.26
2025-04-16	LPTX	0.36	25.5	-	-1.26
2025-04-17	LPTX	0.36	25.5	-	-1.26
2025-04-18	LPTX	0.36	25.5	-	-1.26
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-03-21	LPTX	0.00	-5.34	6.62
2025-03-24	LPTX	0.00	-5.34	6.62
2025-03-25	LPTX	0.00	-5.34	6.62
2025-03-26	LPTX	0.00	-5.34	5.38
2025-03-27	LPTX	0.00	-5.34	5.38
2025-03-28	LPTX	0.00	-5.34	5.38
2025-03-31	LPTX	0.00	-4.98	5.00
2025-04-01	LPTX	0.00	-4.98	5.00
2025-04-02	LPTX	0.00	-4.98	5.00
2025-04-03	LPTX	0.00	-4.98	5.00
2025-04-04	LPTX	0.00	-4.98	5.00
2025-04-07	LPTX	0.00	-5.34	5.02
2025-04-08	LPTX	0.00	-5.34	5.02
2025-04-09	LPTX	0.00	-5.34	5.02
2025-04-10	LPTX	0.00	-5.34	12.45
2025-04-11	LPTX	0.00	-5.34	12.45
2025-04-14	LPTX	0.00	-5.34	12.45
2025-04-15	LPTX	0.00	-5.34	12.45
2025-04-16	LPTX	0.00	-5.34	12.45
2025-04-17	LPTX	0.00	-5.34	12.45
2025-04-18	LPTX	0.00	-5.34	12.45
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-0.37

Avg. EPS Est. Current Quarter

-0.38

Avg. EPS Est. Next Quarter

-0.35

Insider Transactions

Institutional Transactions

-5.34

Beta

-0.23

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

99.1

Max Drawdown 5-Year %

-99.3

Target Price

6.75

P/E

Forward P/E

PEG

P/S

P/B

0.4

P/Free Cash Flow

EPS

-1.84

Average EPS Est. Cur. Y

-1.26

EPS Next Y. (Est.)

-0.87

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.12

Return on Equity vs Sector %

-213.4

Return on Equity vs Industry %

-200

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.1

EBIT Estimation

Leap Therapeutics, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 52

Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops antibody therapies for the treatment of cancer. Its lead product candidates include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric and gynecologic cancers, and colorectal cancer. The company is also developing FL-501, a monoclonal antibody that inhibits GDF-15 protein that is in preclinical trial. It has an option and license agreement with Adimab, LLC and BeiGene, Ltd. to develop and commercialize DKN-01 in Asia (excluding Japan), Australia, and New Zealand. The company was formerly known as HealthCare Pharmaceuticals, Inc. and changed its name to Leap Therapeutics, Inc. in November 2015. Leap Therapeutics, Inc. was incorporated in 2011 and is based in Cambridge, Massachusetts.

stock quote shares LPTX – Leap Therapeutics Inc Stock Price stock today

news today LPTX – Leap Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch LPTX – Leap Therapeutics Inc yahoo finance google finance

stock history LPTX – Leap Therapeutics Inc invest stock market

stock prices LPTX premarket after hours

ticker LPTX fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: LPTX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y